Skip to main content
Cross-sectional study finds metabolic dysregulation in RA-ILD is indicative of poor prognosis- FGF-21 assoc w. poor surv

Mrinalini Dey DrMiniDey

1 year 10 months ago
Cross-sectional study finds metabolic dysregulation in RA-ILD is indicative of poor prognosis- FGF-21 assoc w. poor survival. Another link btwn CV risk factors, metabolic syndrome & RA? Should we be doing more to manage metabolic risk factors in RA-ILD? Ab0803 #ACR24 @RheumNow
Hamroun et al. Meta-analysis of glucocorticoids in pregnancy and breast-feeding. Increase pre-term birth with GCs, adjus

Richard Conway RichardPAConway

1 year 10 months ago
Hamroun et al. Meta-analysis of glucocorticoids in pregnancy and breast-feeding. Increase pre-term birth with GCs, adjusted OR 2.24. Dose-dependent effect. Minimal breastmilk transfer. @RheumNow #ACR24 Abstr#0810 https://t.co/H0o9ElsHmc https://t.co/uciFP6UOhF
Prof @WalterMaks et al reports the validation of data-driven quantitative MRI cutoffs for a +SIJ MRI perform highly in p

sheila RHEUMarampa

1 year 10 months ago
Prof @WalterMaks et al reports the validation of data-driven quantitative MRI cutoffs for a +SIJ MRI perform highly in pts with established axSpA. - Deep fat lesions & sclerosis: high specificity for #axSpA @RheumNow #ACR24 abs821 https://t.co/sSAtTt1GGV
Not just the presence but higher levels of biomarkers predict RA-ILD progression.
#ACR24 @RheumNow ABST#0804 https://t.c

Jiha Lee JihaRheum

1 year 10 months ago
Not just the presence but higher levels of biomarkers predict RA-ILD progression. #ACR24 @RheumNow ABST#0804 https://t.co/5jhBjXDUeY
Medication-assisted weight loss has boomed in recent yrs. How does weight loss affect disease activity & PROs in RMD

Mrinalini Dey DrMiniDey

1 year 10 months ago
Medication-assisted weight loss has boomed in recent yrs. How does weight loss affect disease activity & PROs in RMDs? ≥5% weight loss, after taking a med, led to better disease activity & QoL Data may inform RCTs to explore effect of these meds in RMDs Ab0845 #ACR24 @RheumNow
LTE of deucravacitinib trials in psoriasis. Remarkable & frankly surprising (to me) persistence of benefitVery enc

Mike Putman EBRheum

1 year 10 months ago

LTE of deucravacitinib trials in psoriasis. Remarkable & frankly surprising (to me) persistence of benefit Very encouraging for patients who start TYKs, looks like those who respond may have prolonged benefit #ACR24 @RheumNow Abstr#0290 #ACRBest https://t.co/kao4vqpPTQ

JAK-pot! How fast do DMARDs work?
Studies show that patients with difficult-to-manage axSpA have a higher disease activity; however, the lack of a consensus definition led researchers and clinicians to utilize their own proposed definition, resulting in variability of the characteristics of non-responders.
Don’t miss the “window of opportunity” for aggressive treatment in early RA!

with active RA, risk of ILD 6x and

Jiha Lee JihaRheum

1 year 10 months ago
Don’t miss the “window of opportunity” for aggressive treatment in early RA! with active RA, risk of ILD 6x and RA-related lung disease 4x higher #ACR24 @RheumNow ABST#0802 https://t.co/yxlfInte6A
Cannabis in Pain:
CBD can help with nociceptive pain
THC better for neuropathic, centralized pain
Perhaps a role in hel

Eric Dein ericdeinmd

1 year 10 months ago
Cannabis in Pain: CBD can help with nociceptive pain THC better for neuropathic, centralized pain Perhaps a role in helping decrease other medications like opiates Clauw 16S18 #ACR24 @RheumNow https://t.co/kaQXrD4GAn
How often should #scleroderma #ILD pts have #PFTs? 🤷‍♂️

Data from SENCIS RCT of SSc-ILD

25% worsened FVC b

Janet Pope Janetbirdope

1 year 10 months ago
How often should #scleroderma #ILD pts have #PFTs? 🤷‍♂️ Data from SENCIS RCT of SSc-ILD 25% worsened FVC by 6/12 Are we UNDER a ordering PFTs in an ILD #SSc population 👇 Because if worsening we would consider a change in background #immunesuppression @RheumNow #ACR24 #678 https://t.co/a9ybO3FwDd
Abstract #0805
Data from OTIS Registry shows Certolizumab pegol (Cimzia) exposure during pregnancy was not associated wi

Akhil Sood MD AkhilSoodMD

1 year 10 months ago
Abstract #0805 Data from OTIS Registry shows Certolizumab pegol (Cimzia) exposure during pregnancy was not associated with increased risk of major birth defects, structural defects, or adverse pregnancy outcomes. #ACR24 @RheumNow
Does alcohol consumption affect radiographic progression in axSpA?

Canadian cohort study over 6 years found greater rad

Adela Castro AdelaCastro222

1 year 10 months ago
Does alcohol consumption affect radiographic progression in axSpA? Canadian cohort study over 6 years found greater radiographic progression among alcohol consumers. Still a lot of confounding factors to fully establish an association. Abst#0822 #ACR24 @RheumNow https://t.co/GG0rXq3kjC
×